MEESSI-AHF Score: Explanation and Clinical Context MEESSI-AHF Score is a validated risk stratification tool for patients admitted with acute heart failure.
It predicts in-hospital and 30-day post-discharge mortality using variables readily available at hospital admission, including age, systolic blood pressure, heart rate, renal function (BUN, creatinine), cardiac biomarkers (troponin, BNP/NT-proBNP), and prior heart failure history.
The total score stratifies patients into low, intermediate, high, or very high risk categories, guiding clinical decision-making for monitoring intensity, therapeutic interventions, and discharge planning.
Reference:
Mart�-Almor J, et al. Development and validation of the MEESSI-AHF risk score for acute heart failure. *Eur Heart J*. 2017;38:3232�3241. doi:10.1093/eurheartj/ehx467
Mart�nez-Sell�s M, et al. The MEESSI-AHF risk score: practical application in clinical care. *Rev Esp Cardiol (Engl Ed)*. 2019;72:338�347.